Fig. 8
A forest plot displaying the prevalence of treatment emergent adverse events in the baricitinib group versus the placebo group
Fig. 8 | BMC Rheumatology
A forest plot displaying the prevalence of treatment emergent adverse events in the baricitinib group versus the placebo group